Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Unexpected clinical course during treatment of a TSH-secreting pituitary adenoma.

Glynn N, Agha A.

Endocr Pract. 2013 Jul-Aug;19(4):e88-91. doi: 10.4158/EP13036.CR.

PMID:
23512395
2.

Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.

Teramoto A, Sanno N, Tahara S, Osamura YR.

Acta Neuropathol. 2004 Aug;108(2):147-53. Epub 2004 Jun 5.

PMID:
15185102
3.

Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995).

Warnet A, Lajeunie E, Gelbert F, Duet M, Chanson P, Cophignon J, Harris AG.

Acta Endocrinol (Copenh). 1991 Apr;124(4):487-91.

PMID:
2031445
4.

Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.

Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.

J Clin Endocrinol Metab. 2001 Jun;86(6):2849-53.

PMID:
11397898
5.

A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment.

Polak M, Bertherat J, Li JY, Kujas M, Le Dafniet M, Weizani H, Van Effenterre R, Epelbaum J, Turpin G.

Acta Endocrinol (Copenh). 1991 Apr;124(4):479-86.

PMID:
1851593
6.

Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.

Horiguchi K, Yamada M, Umezawa R, Satoh T, Hashimoto K, Tosaka M, Yamada S, Mori M.

Endocr J. 2007 Jun;54(3):371-8. Epub 2007 Apr 10.

7.

Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.

Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.

Thyroid. 2015 Aug;25(8):877-82. doi: 10.1089/thy.2015.0041.

PMID:
26244412
8.

Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).

Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F.

J Clin Endocrinol Metab. 1996 Mar;81(3):1164-8.

PMID:
8772594
9.

[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.

Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.

Q J Nucl Med. 1995 Dec;39(4 Suppl 1):90-3.

PMID:
9002759
10.

Plurihormonal pituitary adenoma immunoreactive for thyroid-stimulating hormone, growth hormone, follicle-stimulating hormone, and prolactin.

Luk CT, Kovacs K, Rotondo F, Horvath E, Cusimano M, Booth GL.

Endocr Pract. 2012 Sep-Oct;18(5):e121-6. doi: 10.4158/EP12033.CR.

PMID:
22441009
11.

Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).

Lee EJ, Kim KR, Lim SK, Lee HC, Kim DI, Kim SH, Huh KB.

Eur J Endocrinol. 1994 Jul;131(1):109-12.

PMID:
8038902
12.

Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.

Gancel A, Vuillermet P, Legrand A, Catus F, Thomas F, Kuhn JM.

Clin Endocrinol (Oxf). 1994 Mar;40(3):421-8.

PMID:
8187308
13.

Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.

Gatto F, Barbieri F, Gatti M, Wurth R, Schulz S, Ravetti JL, Zona G, Culler MD, Saveanu A, Giusti M, Minuto F, Hofland LJ, Ferone D, Florio T.

Clin Endocrinol (Oxf). 2012 Mar;76(3):407-14. doi: 10.1111/j.1365-2265.2011.04200.x.

PMID:
21848909
14.
15.

Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients.

Chanson P, Weintraub BD, Harris AG.

Ann Intern Med. 1993 Aug 1;119(3):236-40.

PMID:
8323093
17.

Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.

Gruszka A, Zielinski GM, Kunert-Radek J.

J Clin Neurosci. 2014 Feb;21(2):340-2. doi: 10.1016/j.jocn.2013.02.038. Epub 2013 Aug 16.

PMID:
23958483
18.

Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.

Hubalewska-Hola A, Fröss K, Kostecka-Matyja M, Sowa-Staszczak A, Szybiński Z, Huszno B, Ptak M.

Przegl Lek. 2003;60(11):768-71.

PMID:
15058054
19.

TSH secreting pituitary adenoma: a rare cause of thyrotoxicosis.

So WY, Yeung VT, Chow CC, Ko GT, Szeto CC, Cockram CS.

Int J Clin Pract. 1998 Jan-Feb;52(1):62-4.

PMID:
9536575
20.

Diagnosis and treatment of pituitary adenomas.

Chanson P, Salenave S.

Minerva Endocrinol. 2004 Dec;29(4):241-75. Review.

Items per page

Supplemental Content

Write to the Help Desk